Observational studyThe European respiratory journal2024

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.

David J Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.